Not for HVDPs? [NCA / SHAM]

posted by Helmut Homepage – Vienna, Austria, 2021-10-04 14:05 (1327 d 05:30 ago) – Posting: # 22618
Views: 4,603

Dear Detlew,

❝ ❝ One of my 4-period full replicate studies (143 subjects, Method A)


❝ Looks not too bad for a log-normal ;-).


More details… The reference formulation in this study was terrible; CVwR twice of CVwT, many subjects with low AUCs after R. Distributions of studentized model residuals heavy-tailed. Since CVwT <30%, this was a HVDP and not a HVD. Adjusting the AUC would make things worse.
90% CIs (Method B, Satterthwaite’s df):
AUC0–∞:    111.17 – 123.79%
AUC0–∞·k: 113.89 – 132.70%

[image]

[image]


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
60 visitors (0 registered, 60 guests [including 13 identified bots]).
Forum time: 19:36 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5